» Articles » PMID: 23233342

[Social Integration After 4 Years of Heroin-assisted Treatment]

Overview
Date 2012 Dec 13
PMID 23233342
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Studies from several countries have by now shown the effectiveness of heroin-assisted treatment in comparison to methadone treatment. However, only few long-term results exist, and in particular data with a focus on social integration of the patients are scarce.

Objective: The study analyzes the course of long-term social integration among the patients of the German diamorphine study.

Methods: Individual changes in health, drug use and social integration among patients who had participated in a 4-year diamorphine treatment (n=156) were described and statistically tested by means of repeated measures analyses. The criteria used are based on the instruments OTI-HSS and SCL-90-R, on medical findings, urinalyses, and on variables as well as composite scores from the European Addiction Severity Index.

Results: In all domains significant improvements were found after long-term treatment. The percentage of patients employed or currently working had increased 3-fold up to 40% after 4 years. Moreover, the living situation and leisure behaviour improved, and criminal activities declined markedly. The main influencing factor for successful social integration after 4 years of treatment is the ability to work.

Conclusions: Heroin-assisted treatment is a long-term effective treatment for severely dependent opiate addicts with respect to stabilization of health, reduction of illegal drug use and improvement of social integration. Furthermore, the results show that processes of social (re-)integration of drug users take time.

Citing Articles

Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities.

Friedmann Z, Kinkel H, Kuhner C, Zsolnai A, Mick I, Binder A Harm Reduct J. 2023; 20(1):162.

PMID: 37915058 PMC: 10619267. DOI: 10.1186/s12954-023-00896-6.


The opiate dosage adequacy scale for identification of the right methadone dose--a prospective cohort study.

Walcher S, Koc J, Reichel V, Schlote F, Verthein U, Reimer J BMC Pharmacol Toxicol. 2016; 17:15.

PMID: 27052201 PMC: 4823862. DOI: 10.1186/s40360-016-0058-9.


Differential long-term outcomes for voluntary and involuntary transition from injection to oral opioid maintenance treatment.

Oviedo-Joekes E, Guh D, Marchand K, Marsh D, Lock K, Brissette S Subst Abuse Treat Prev Policy. 2014; 9:23.

PMID: 24908387 PMC: 4064505. DOI: 10.1186/1747-597X-9-23.


When higher doses in opioid replacement treatment are still inadequate - association to multidimensional illness severity: a cohort study.

Reimer J, Boniakowski E, Bachner C, Weber B, Tietje W, Verthein U Subst Abuse Treat Prev Policy. 2014; 9:13.

PMID: 24581310 PMC: 3975916. DOI: 10.1186/1747-597X-9-13.